David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$602M |
| 2 |
Booking.com
BKNG
|
+$582M |
| 3 |
Walmart Inc
WMT
|
+$407M |
| 4 |
Visa
V
|
+$395M |
| 5 |
Johnson & Johnson
JNJ
|
+$335M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$483M |
| 2 |
Salesforce
CRM
|
+$380M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$364M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$336M |
| 5 |
Colgate-Palmolive
CL
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.49% |
| 2 | Consumer Discretionary | 9.18% |
| 3 | Healthcare | 8.57% |
| 4 | Financials | 8% |
| 5 | Industrials | 4.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3776
PUT
Robinhood
HOOD
$101B
| $189K | ﹤0.01% |
19,500
-183,500
| -90% | -$1.75M |
|
|
KYNB
3777
Kyntra Bio
KYNB
$32.8M
| $188K | ﹤0.01% |
+404
| New | +$214K |
|
|
CONN
3778
PUT
DELISTED
Conn's Inc.
CONN
| $188K | ﹤0.01% |
31,100
| – | – |
|
|
AVPTW
3779
DELISTED
AvePoint Inc Warrant
AVPTW
| $187K | ﹤0.01% |
330,794
+100
| +0% | +$68 |
|
3780
Patria Investments
PAX
$1.9B
| $186K | ﹤0.01% |
+12,559
| New | +$191K |
|
3781
ALX Oncology
ALXO
$277M
| $186K | ﹤0.01% |
41,075
+15,152
| +58% | +$115K |
|
3782
Advantage Solutions
ADV
$432M
| $185K | ﹤0.01% |
4,692
-4,386
| -48% | -$248K |
|
|
GORV
3783
DELISTED
Lazydays
GORV
| $185K | ﹤0.01% |
528
+96
| +22% | +$36.1K |
|
|
DNMR
3784
DELISTED
Danimer Scientific, Inc.
DNMR
| $182K | ﹤0.01% |
1,317
+164
| +14% | +$15K |
|
3785
Inseego
INSG
$74.4M
| $181K | ﹤0.01% |
31,139
-5,899
| -16% | -$52.4K |
|
|
SCU
3786
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $181K | ﹤0.01% |
21,032
+10,866
| +107% | +$97.5K |
|
|
MGI
3787
DELISTED
MoneyGram International, Inc. New
MGI
| $178K | ﹤0.01% |
17,100
-946
| -5% | -$10.2K |
|
3788
1stdibs.com
DIBS
$151M
| $178K | ﹤0.01% |
44,856
+15,379
| +52% | +$78.2K |
|
3789
Kelly Services Class A
KELYA
$591M
| $177K | ﹤0.01% |
10,642
-8,540
| -45% | -$145K |
|
3790
Stereotaxis
STXS
$141M
| $176K | ﹤0.01% |
86,250
-113,045
| -57% | -$254K |
|
|
ARI
3791
Apollo Commercial Real Estate
ARI
$880M
| $175K | ﹤0.01% |
18,835
-28,468
| -60% | -$315K |
|
|
LILM
3792
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $175K | ﹤0.01% |
+268,849
| New | +$285K |
|
3793
Hertz
HTZ
$795M
| $174K | ﹤0.01% |
+10,700
| New | +$187K |
|
3794
Sasol
SSL
$7.34B
| $174K | ﹤0.01% |
+12,749
| New | +$198K |
|
3795
Gossamer Bio
GOSS
$100M
| $172K | ﹤0.01% |
136,175
-179,450
| -57% | -$344K |
|
|
DMTK
3796
DELISTED
DermTech, Inc. Common Stock
DMTK
| $168K | ﹤0.01% |
45,715
-208,585
| -82% | -$878K |
|
3797
RPC Inc
RES
$1.36B
| $168K | ﹤0.01% |
21,860
-106,938
| -83% | -$951K |
|
|
BDN
3798
Brandywine Realty Trust
BDN
$565M
| $168K | ﹤0.01% |
35,450
-602,774
| -94% | -$3.54M |
|
|
NXDR
3799
Nextdoor Holdings
NXDR
$925M
| $167K | ﹤0.01% |
77,900
+22,900
| +42% | +$48.9K |
|
3800
Atea Pharmaceuticals
AVIR
$436M
| $166K | ﹤0.01% |
49,698
+9,476
| +24% | +$38.4K |
|
Similar funds
David Shaw's Q1 2023 Portfolio in Review
As of Q1 2023, David Shaw held 5,246 positions worth $93.4B, up 3.2% from $90.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $9.17B in Q1 2023, closing 860 positions and reducing 1,787 holdings. Its most notable exit was SVB Financial Group, an estimated $163M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in State Street Utilities Select Sector SPDR ETF worth $99.9M.
- David Shaw's largest Q1 2023 buy was State Street Utilities Select Sector SPDR ETF: 2,950,552 shares worth $99.9M.
- David Shaw added most to Charles Schwab in Q1 2023, an estimated $602M increase.
- David Shaw's biggest Q1 2023 reduction was Microsoft, cutting an estimated $483M.
- David Shaw fully exited SVB Financial Group in Q1 2023, selling an estimated $163M.
- David Shaw's ten largest holdings make up 11% of its $93.4B portfolio in Q1 2023.
- David Shaw opened 431 new positions and closed 860 in Q1 2023.
- David Shaw's portfolio value rose 3.2% quarter-over-quarter to $93.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.